Suppr超能文献

伊曲康唑口服溶液采用隔周脉冲疗法治疗实验性犬小孢子菌感染猫的疗效。

Efficacy of itraconazole oral solution using an alternating-week pulse therapy regimen for treatment of cats with experimental Microsporum canis infection.

作者信息

Puls Christopher, Johnson Aaron, Young Karrie, Hare Jonathan, Rosenkrans Kelly, Young Lisa, Moriello Karen

机构信息

1 Elanco Animal Health, Greenfield, IN, USA.

2 Kingfisher International, Stouffville, ON, Canada.

出版信息

J Feline Med Surg. 2018 Oct;20(10):869-874. doi: 10.1177/1098612X17735967. Epub 2017 Oct 13.

Abstract

Objectives The objective of this study was to evaluate itraconazole 10 mg/ml oral solution for the treatment of Microsporum canis infection using an alternating-week pulse therapy regimen in a controlled laboratory setting. Methods Eighty cats with experimentally induced infections were randomly assigned to treatment (itraconazole vs control [sterile water]), administered 5 mg/kg PO q24h for 1 week on alternate weeks for 5 weeks, followed by a 4 week follow-up period. Topical therapeutic treatment was not administered. Cats were individually housed in stainless steel cages that were cleaned and disinfected daily. Study measures included weekly fungal cultures, clinical lesion scores, Wood's lamp examination and periodic laboratory monitoring. Mycological cure was defined as two consecutive negative cultures. Results Itraconazole-treated cats had significantly greater ( P = 0.0003) mycological cure compared with untreated controls (24/40 [60%] vs 1/40 [2.5%], respectively) and all of these reached clinical cure and had negative final Wood's lamp examinations. Furthermore, 36/40 (90%) treated cats had at least one negative fungal culture by the end of the study vs only 3/40 (7.5%) control cats. For both treatment groups, prevalence of clinical cure peaked at the end of the study (week 9), with 39/40 (97.5%) itraconazole-treated cats and 6/40 (15%) control cats achieving clinical cure. Wood's lamp negative examination rates were significantly greater ( P <0.0001) for itraconazole-treated cats compared with controls (39/40 cats [97.5%] vs 6/40 [15%], respectively) and followed the same pattern of improvement as primary clinical lesions. Conclusions and relevance In this controlled study, orally administered itraconazole using a 5 mg/kg pulse-dose treatment regimen reduced the time to mycological cure and increased both mycological and clinical cure rates compared with untreated controls.

摘要

目的 本研究的目的是在可控的实验室环境中,使用隔周脉冲疗法方案评估10mg/ml伊曲康唑口服溶液治疗犬小孢子菌感染的效果。方法 将80只实验性诱导感染的猫随机分为治疗组(伊曲康唑组与对照组[无菌水]),每隔一周口服给药5mg/kg,每日一次,共1周,持续5周,随后进行4周的随访期。未给予局部治疗。猫单独饲养在每天清洁和消毒的不锈钢笼中。研究指标包括每周真菌培养、临床病变评分、伍德灯检查和定期实验室监测。真菌学治愈定义为连续两次培养阴性。结果 与未治疗的对照组相比,伊曲康唑治疗的猫真菌学治愈率显著更高(P = 0.0003)(分别为24/40 [60%] 对1/40 [2.5%]),所有这些猫均达到临床治愈且最终伍德灯检查为阴性。此外,在研究结束时,36/40(90%)接受治疗的猫至少有一次真菌培养阴性,而对照组猫仅3/40(7.5%)。对于两个治疗组,临床治愈率在研究结束时(第9周)达到峰值,39/40(97.5%)接受伊曲康唑治疗的猫和6/40(15%)对照组猫实现临床治愈。与对照组相比,伊曲康唑治疗的猫伍德灯阴性检查率显著更高(P <0.0001)(分别为39/40只猫 [97.5%] 对6/40 [15%]),并且与主要临床病变的改善模式相同。结论及相关性 在这项对照研究中,与未治疗的对照组相比,采用5mg/kg脉冲剂量治疗方案口服伊曲康唑可缩短真菌学治愈时间,并提高真菌学和临床治愈率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0691/11129248/7f82cc972b42/10.1177_1098612X17735967-fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验